Evidence map›Paper›PMID 40856837›Full record

ArticleEuropean spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society2026

Exploring clinical and demographic determinants of time to treatment in spinal metastases: A Large-Scale cohort study of more than 1000 patients.

Stavros Matsoukas, Sean Inzerillo, Matthew Carr, Michael Lemonick, Roshini Kalagara, Bahie Ezzat, Priya Bhanot, Cole Brown, Mehek Dedhia, Gavin Kress and 3 more

Abstract read
PubMed Publisher
In one paragraph

Article in European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Stavros MatsoukasMount Sinai Hospital, New York, United States. stavrosmatsoukas@hotmail.com.
Sean InzerilloSUNY Downstate Medical Center, Brooklyn, United States.
Matthew CarrMount Sinai Hospital, New York, United States.
Michael LemonickMount Sinai Hospital, New York, United States.
Roshini KalagaraMount Sinai Hospital, New York, United States.
Bahie EzzatMount Sinai Hospital, New York, United States.
Priya BhanotMount Sinai Hospital, New York, United States.
Cole BrownMount Sinai Hospital, New York, United States.
Mehek DedhiaMount Sinai Hospital, New York, United States.
Gavin KressMount Sinai Hospital, New York, United States.
Amish DoshiMount Sinai Hospital, New York, United States.
Konstantinos MargetisMount Sinai Hospital, New York, United States.
Patrick ReidMount Sinai Hospital, New York, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo identify predictors for time to first treatment modality (TTT) in patients diagnosed with spinal metastatic disease.

methodsOur radiology database was retrospectively queried to identify patients with spinal metastases (01/2017-12/2021). Demographics, setting of initial imaging (inpatient/outpatient/ED), histology, treatment modality, and TTT were collected. Several different early TTT thresholds were explored (≤ 30, ≤ 21, ≤14, and ≤ 7 days). After controlling for age, gender, diagnostic setting, pathology, type of treatment multivariable linear and logistic regressions were performed for the primary and secondary thresholds at different time-points.

resultsA total of 1009 patients with spinal metastases were included, with a median age of 65 years (IQR 15) and 529 (52.4%) males. Diagnoses occurred in the inpatient (37%), outpatient (50%), and emergency department (13%) settings. The most common primary tumors were breast (22.4%), prostate (19.5%), and non-small cell lung cancer (12.8%). Treatment modalities included surgery (14.6%), chemotherapy (54.5%), and radiation therapy (43.5%). The median time to treatment (TTT) was 13 days (SD 27, range 0-676), with no significant difference by setting (p = 0.2). In multivariable linear regression, surgery was associated with shorter TTT (p = 0.037). Logistic regression using different early-TTT thresholds identified age, surgical intervention, lymphoma, and outpatient setting as significant predictors across models. Sensitivity analyses excluding TTT outliers showed that surgery was no longer a significant predictor, while other covariates remained stable.

conclusionsSurgical intervention and lymphoma independently predicted earlier TTT of any modality in spinal metastases, whereas older age and outpatient diagnosis were associated with delays.

Indexed as

Spinal NeoplasmsTime-to-TreatmentAgedAged, 80 and overCohort StudiesFemaleHumansMaleMiddle AgedRetrospective StudiesTreatment DelayNeurological CompromiseSpinal cord compressionSpinal MetastasesSpine TumorsTime to treatment

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.